RA CAPITAL MANAGEMENT, L.P. - Director, 10%+ Owner at Climb Bio, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
CLYM on Nasdaq
All Insider Reports
All Insider Reports

RA CAPITAL MANAGEMENT, L.P. - trading volume in the past year for Climb Bio, Inc.

Holdings reported by RA CAPITAL MANAGEMENT, L.P. for Climb Bio, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3,403,429 $11,912,001 $3.50 05 Jan 2026 Indirect
Pre-Funded Warrants (Right to Buy) 20,440,000 11 Dec 2025 Indirect Common Stock
Stock Option (Right to Buy) 40,000 04 Jun 2025 Indirect Common Stock

Transactions reported by RA CAPITAL MANAGEMENT, L.P. for Climb Bio, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.